</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
true true {{custommediabasic::headline_less_padding_bottom}} #00194A #CF152D {{custommediabasic::custom_background}} 30px 0 30px 0 {{custommediabasic::logo_url}} {{custommediabasic::logo}} {{custommediabasic::logo_alt_text}} 200 {{custommediabasic::logo_at_bottom}} {{custommediabasic::header_image_url}} /uploads/i_stock_966381224-c66d017edef4bf41f00edd94f3f30ec0.jpg {{custommediabasic::header_image_alt_text}} The Efficacy and Safety of the Injectable Anesthetic Tiletamine-Zolazepam in Dogs and Cats CE WEBINAR {{custommediabasic::subhead_url}} true {{custommediabasic::headline_subhead_below_header_image}}

Zoletil™ (tiletamine and zolazepam) for Injection is an effective, dependable, low-volume injectable anesthetic for healthy dog or cat procedures. Watch this 30 minute RACE-approved webinar, as Elizabeth Martinez, DVM, DACVAA walks us through:

  • Full characteristic overviews of each active ingredient and how they work
  • Demonstrations on flexibility of anesthesia levels
  • A review of dosing and administration directions for optimal use
#888888 true true true {{custommediabasic::cta_callout_secondary}} https://www.thinkanesthesia.education/on-demand-webinar/2020/07/the-efficacy-and-safety-of-the-injectable-anesthetic-tiletamine-zolazepam Gain Anesthetic Confidence. Watch Now {{custommediabasic::footnote_center}}

View Product Information here.

View Prescribing Information here.

Important Safety Information

As with all drugs, side effects may occur. Zoletil™ for Injection should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section since a study has shown that tiletamine and zolazepam injection crosses the placental barrier. Do not use phenothiazine-derivative drugs concomitantly with Zoletil™ for Injection as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Zoletil™. Copious salivation may occur during Zoletil™ anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Zoletil™. For complete prescribing information visit https://www.jurox.com/us/product/zoletil-injection.

{{custommediabasic::footnote_larger}} {{custommediabasic::pre_footer_center}} {{custommediabasic::pre_footer_larger}} {{custommediabasic::pre_footer_copy}}
{{custommediabasic::preview_text}}
The Efficacy and Safety of the Injectable Anesthetic
Tiletamine-Zolazepam in Dogs and Cats
CE WEBINAR
{{custommediabasic::header_image_alt_text}}

Zoletil™ (tiletamine and zolazepam) for Injection is an effective, dependable, low-volume injectable anesthetic for healthy dog or cat procedures. Watch this 30 minute RACE-approved webinar, as Elizabeth Martinez, DVM, DACVAA walks us through:

  • Full characteristic overviews of each active ingredient and how they work
  • Demonstrations on flexibility of anesthesia levels
  • A review of dosing and administration directions for optimal use
Gain Anesthetic Confidence.
Gain Anesthetic Confidence.
Watch Now

View Product Information here.

View Prescribing Information here.

Important Safety Information

As with all drugs, side effects may occur. Zoletil™ for Injection should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section since a study has shown that tiletamine and zolazepam injection crosses the placental barrier. Do not use phenothiazine-derivative drugs concomitantly with Zoletil™ for Injection as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Zoletil™. Copious salivation may occur during Zoletil™ anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Zoletil™. For complete prescribing information visit https://www.jurox.com/us/product/zoletil-injection.

</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
{{custommediabasic::preview_text}}
The Efficacy and Safety of the Injectable Anesthetic
Tiletamine-Zolazepam in Dogs and Cats
CE WEBINAR
{{custommediabasic::header_image_alt_text}}

Zoletil™ (tiletamine and zolazepam) for Injection is an effective, dependable, low-volume injectable anesthetic for healthy dog or cat procedures. Watch this 30 minute RACE-approved webinar, as Elizabeth Martinez, DVM, DACVAA walks us through:

  • Full characteristic overviews of each active ingredient and how they work
  • Demonstrations on flexibility of anesthesia levels
  • A review of dosing and administration directions for optimal use
Gain Anesthetic Confidence.
Gain Anesthetic Confidence.
Watch Now

View Product Information here.

View Prescribing Information here.

Important Safety Information

As with all drugs, side effects may occur. Zoletil™ for Injection should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section since a study has shown that tiletamine and zolazepam injection crosses the placental barrier. Do not use phenothiazine-derivative drugs concomitantly with Zoletil™ for Injection as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Zoletil™. Copious salivation may occur during Zoletil™ anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Zoletil™. For complete prescribing information visit https://www.jurox.com/us/product/zoletil-injection.